Research Topics
| L M BrassSummaryAffiliation: Yale University Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
The use of warfarin in veterans with atrial fibrillationDawn M Bravata
Clinical Epidemiology Research Center, VA Connecticut Healthcare System, 950 Campbell Avenue 11C 2, West Haven, CT 06516, USA
BMC Cardiovasc Disord 4:18. 2004..The purpose of this study was to examine the use of warfarin in both inpatients and outpatients with atrial fibrillation within a Veterans Affairs (VA) hospital system...
Warfarin use among patients with atrial fibrillationL M Brass
Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Conn, USA
Stroke 28:2382-9. 1997..Warfarin reduces the rate of stroke among patients with atrial fibrillation. We sought to determine warfarin use within a population sample of elderly patients with atrial fibrillation...
Bone marrow for the brain?Lawrence M Brass
Department of Neurology, Yale University School of Medicine, New Haven, CT 06520 8018, USA
Exp Neurol 199:16-9. 2006
Hormone replacement therapy and stroke: clinical trials reviewLawrence M Brass
Department of Neurology, LCI 700, Yale University School of Medicine, PO Box 208018, 15 York Street, New Haven, CT 06520 8018, USA
Stroke 35:2644-7. 2004..As a result of these trials, the portion of postmenopausal women using hormone replacement therapy in the United States has fallen by more than half over the past decade...
The impact of cerebrovascular diseaseL M Brass
Department of Neurology, LCI 7, Yale University School of Medicine, 15 York Street, Box 208018, New Haven, CT 06520, USA
Diabetes Obes Metab 2:S6-10. 2000..Interventions that result in reduction of stroke will likely result in decreased health care costs and improved clinical outcomes...
Warfarin use following ischemic stroke among Medicare patients with atrial fibrillationL M Brass
Center for Outcomes Research and Evaluation, Yale New Haven Hospital, Yale University School of Medicine, Conn 06520 8018, USA
Arch Intern Med 158:2093-100. 1998..Elderly patients with ischemic stroke and atrial fibrillation are at especially increased risk for recurrent stroke. Warfarin sodium is highly effective in reducing this risk...
Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicityS C Johnston
Neurovascular Service, Department of Neurology, University of California, San Francisco, CA 94143 0114, USA
Stroke 32:1061-8. 2001..We sought to measure the overall rate of usage of tissue-type plasminogen activator (tPA) for ischemic stroke at academic medical centers, and to determine whether ethnicity was associated with usage...
Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiableJoseph P Broderick
Department of Neurology, University of Cincinnati, College of Medicine, Cincinnati, Ohio 45267, USA
Stroke 34:1375-81. 2003..To identify risk factors for subarachnoid hemorrhage (SAH) and intracerebral hemorrhage, we designed a case-control study of men and women 18 to 49 years of age (the Hemorrhagic Stroke Project [HSP]). This report focuses on SAH...
A clinical trial of estrogen-replacement therapy after ischemic strokeC M Viscoli
Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn. 06520-8056, USA
N Engl J Med 345:1243-9. 2001..CONCLUSIONS: Estradiol does not reduce mortality orthe recurrence of stroke in postmenopausal women with cerebrovascular disease. This therapy should not be prescribed for the secondary prevention of cerebrovascular disease...
The stroke prognosis instrument II (SPI-II) : A clinical prediction instrument for patients with transient ischemia and nondisabling ischemic strokeW N Kernan
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, USA
Stroke 31:456-62. 2000..In this article we validate and improve SPI-I (creating SPI-II)...
Blood pressure exceeding national guidelines among women after strokeW N Kernan
Departments of Internal Medicine, Yale University School of Medicine, New Haven, CT 06504, USA
Stroke 31:415-9. 2000..The purpose of this study was to determine how commonly blood pressure exceeds national guidelines among patients who have had one of these events...
Boosting enrollment in neurology trials with Local Identification and Outreach Networks (LIONs)W N Kernan
Departments of Internal Medicine, Yale School of Medicine, New Haven, CT 06519, USA
Neurology 72:1345-51. 2009..Our purpose was to develop a geographically localized, multi-institution strategy for improving enrolment in a trial of secondary stroke prevention...
A quality-of-life instrument for young hemorrhagic stroke patientsA G Hamedani
Yale University School of Medicine, New Haven, CT, USA
Stroke 32:687-95. 2001..CONCLUSIONS: HSQuale is a reliable and valid QOL instrument. Compared with other outcome measures, it assesses a broader range of deficits and is better able to discriminate among subgroups of hemorrhagic stroke survivors...
Insulin resistance and risk for strokeW N Kernan
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA
Neurology 59:809-15. 2002..Insulin resistance is also common among nondiabetic individuals, and may be an important risk factor for stroke in both populations. The authors review the definition, epidemiology, and treatment of insulin resistance...
Hyperglycaemia in patients with acute ischaemic stroke: how often do we screen for undiagnosed diabetes?D M Bravata
Clinical Epidemiology Research Center, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, USA
QJM 96:491-7. 2003..The under-diagnosis of diabetes in the general population, combined with the association of diabetes and stroke, suggests a rationale for screening for diabetes among hyperglycaemic stroke patients...
Decline in physical performance among women with a recent transient ischemic attack or ischemic stroke: opportunities for functional preservation a report of the Women's Estrogen Stroke TrialWalter N Kernan
Department of Medicine, Yale University School of Medicine, P O Box 208025, New Haven, CT 06520 8025, USA
Stroke 36:630-4. 2005..To examine this possibility, we measured change in physical performance, independent of subsequent stroke, among women with a recent ischemic stroke or transient ischemic attack (TIA)...
Vascular disease among hospitalized multiple sclerosis patientsNorrina B Allen
Section of Chronic Disease Epidemiology, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Conn, USA
Neuroepidemiology 30:234-8. 2008..We examined the prevalence of cardiac and cerebrovascular disease among hospitalized patients with and without multiple sclerosis (MS)...
Two measures of insulin sensitivity provided similar information in a U.S. populationDawn M Bravata
Clinical Epidemiology Unit, Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA
J Clin Epidemiol 57:1214-7. 2004..This project describes the range of observed values of the HOMA and FPI in a large sample of the U.S. population...
Dietary fish or seafood consumption is not related to cerebrovascular disease risk in twin veteransDawn M Bravata
Clinical Epidemiology Research Center, VA Connecticut Healthcare System, West Haven, CN 06516, USA
Neuroepidemiology 28:186-90. 2007..The results of studies about dietary fish consumption and stroke risk have been conflicting. We sought to examine the relationship between dietary fish and seafood consumption and the risk of stroke or transient ischemic attack (TIA)...
Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic strokeWalter N Kernan
Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06520 8025, USA
Arch Intern Med 165:227-33. 2005..We conducted this study to determine if IGT and DGT are sufficiently common among patients with TIA and ischemic stroke to warrant therapeutic trials of antihyperglycemic agents...
Estrogen therapy and risk of cognitive decline: results from the Women's Estrogen for Stroke Trial (WEST)Catherine M Viscoli
Yale University School of Medicine, Department of Internal Medicine, 333 Cedar St, Room IE 61 SHM, PO Box 208025, New Haven, CT 06520 8025, USA
Am J Obstet Gynecol 192:387-93. 2005..This study was undertaken to assess whether estrogen therapy (ET) reduces the risk of cognitive decline in women with cerebrovascular disease...
Association between impaired insulin sensitivity and strokeDawn M Bravata
Clinical Epidemiology Research Center CERC, VA Connecticut Healthcare System, 950 Campbell Avenue, West Haven, CT 06516, USA
Neuroepidemiology 25:69-74. 2005..Prior research has indicated an association between insulin resistance and stroke; we sought to determine if this association persists after adjusting for stroke risk factors, including glycemic control...
Racial disparities in stroke risk factors: the impact of socioeconomic statusDawn M Bravata
Clinical Epidemiology Research Center, Veterans Affairs Connecticut Healthcare System, West Haven, CT 06516, USA
Stroke 36:1507-11. 2005..Our objective was to determine if differences in income, education, and insurance, as well as differences in the prevalence of stroke risk factors, accounted for the association between ethnicity and stroke...
Altruism as a reason for participation in clinical trials was independently associated with adherenceJulie R Rosenbaum
Yale Primary Care Internal Medicine Residency, Waterbury Hospital Health Center, Department of Medicine, CT 06721, USA
J Clin Epidemiol 58:1109-14. 2005..To determine whether altruism as reason for participation in research is independently associated with adherence to a medical regimen in a clinical trial...
Readmission and death after hospitalization for acute ischemic stroke: 5-year follow-up in the medicare populationDawn M Bravata
Clinical Epidemiology Research Center, Veterans Affairs Connecticut Healthcare System, West Haven, CT 06516, USA
Stroke 38:1899-904. 2007..We sought to determine the rates of hospital readmissions and mortality and the reasons for readmission over a 5-year period after stroke...
Informed consent for thrombolytic therapy for patients with acute ischemic stroke treated in routine clinical practiceJulie R Rosenbaum
Department of Internal Medicine, Yale University School of Medicine, West Haven, Conn, USA
Stroke 35:e353-5. 2004..Our objectives were to determine how frequently informed consent is obtained when tPA is given to stroke patients in clinical practice and whether the person providing consent (patient or surrogate) was the appropriate decision-maker...
Pioglitazone improves insulin sensitivity among nondiabetic patients with a recent transient ischemic attack or ischemic strokeWalter N Kernan
Department of Medicine, Yale University School of Medicine, PO Box 208025, New Haven, CT 06520 8025, USA
Stroke 34:1431-6. 2003....
Risk and predictors of stroke after myocardial infarction among the elderly: results from the Cooperative Cardiovascular ProjectJudith H Lichtman
Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, USA
Circulation 105:1082-7. 2002..Stroke is an important outcome after acute myocardial infarction. Studies that have examined this relationship have largely excluded older patients, even though half of stroke admissions occur among patients 75 years of age and older...
Trends in hospitalized stroke for blacks and whites in the United States, 1980-1999Byron S Kennedy
Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Conn 06511, USA
Neuroepidemiology 21:131-41. 2002..Racial differences in stroke mortality are widely recognized, but it is unclear whether or not these differences are due mainly to blacks having a greater stroke incidence or higher case fatality rates compared to those of whites...
Thrombolysis for acute stroke in routine clinical practiceDawn M Bravata
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, USA
Arch Intern Med 162:1994-2001. 2002....
Long-term mortality in cerebrovascular diseaseDawn M Bravata
Medical Service, Veterans Affairs Connecticut Healthcare System, West Haven, Conn, USA
Stroke 34:699-704. 2003..The objectives of this study were to identify predictors of 6-month mortality and to evaluate 5-year mortality in patients with cerebrovascular disease...
Obstructive sleep apnea as a risk factor for stroke and deathH Klar Yaggi
Section of Pulmonary and Critical Care Medicine, Yale Center for Sleep Medicine, Yale University School of Medicine, New Haven, Conn 06520, USA
N Engl J Med 353:2034-41. 2005..005). CONCLUSIONS: The obstructive sleep apnea syndrome significantly increases the risk of stroke or death from any cause, and the increase is independent of other risk factors, including hypertension...
Do the Brain Attack Coalition's criteria for stroke centers improve care for ischemic stroke?V C Douglas
Department of Neurology, University of California, San Francisco, CA 94143 0114, USA
Neurology 64:422-7. 2005..In 2000, the Brain Attack Coalition (BAC) recommended 11 major criteria for the establishment of primary stroke centers. The BAC relied heavily on expert opinion because evidence supporting the criteria was sparse...
Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic strokeW N Kernan
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, USA
Neurology 60:1447-51. 2003..To determine the prevalence of impaired insulin sensitivity among nondiabetic patients with a recent TIA or nondisabling ischemic stroke...
Strategies for primary and secondary stroke preventionLawrence M Brass
Department of Neurology, Yale University School of Medicine, New Haven, Connecticut, USA
Clin Cardiol 29:II21-7. 2006..Together, these data suggest that intensive therapy with agents from multiple drug classes that target two or more risk factors for cerebrovascular disease may provide additive-or even synergistic-reductions in stroke risk...
Use of Ephedra-containing products and risk for hemorrhagic strokeL B Morgenstern
Stroke Program, Department of Neurology, University of Texas at Houston, USA
Neurology 60:132-5. 2003..13 (95% CI 0.01 to 1.54), and for >32 mg/day, the OR was 3.59 (95% CI 0.70 to 18.35). Ephedra is not associated with increased risk for hemorrhagic stroke, except possibly at higher doses...
An assessment of statin safety by neurologistsLawrence M Brass
Yale University, New Haven, Connecticut, USA
Am J Cardiol 97:86C-88C. 2006..In addition, the Neurology Expert Panel was asked to propose recommendations to regulatory authorities, health professionals, patients, researchers, and the pharmaceutical industry to address statin safety issues...
Long-term consequences of upper extremity peripheral neuropathy in former Vietnam prisoners of warEric S Holmboe
Primary Care Internal Medicine Program, Yale University School of Medicine, New Haven, CT, USA
Mil Med 167:736-41. 2002..More research concerning physical symptoms and conditions among former POWs is needed, and this research should also investigate what causes are responsible for the significantly lower physical functional status...
Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing CouncLarry B Goldstein
Circulation 113:e873-923. 2006..CONCLUSIONS: Extensive evidence is available identifying a variety of specific factors that increase the risk of a first stroke and providing strategies for reducing that risk...
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood InstituteSidney C Smith
Circulation 113:2363-72. 2006
Clinical assessment of function among women with a recent cerebrovascular event: a self-reported versus performance-based measurePamela L Owens
Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
Ann Intern Med 136:802-11. 2002..Self-reported functional status is a commonly used health measure in clinical settings, yet the optimal approach for assessing function is often debated...
Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing CouncLarry B Goldstein
Stroke 37:1583-633. 2006..CONCLUSIONS: Extensive evidence is available identifying a variety of specific factors that increase the risk of a first stroke and providing strategies for reducing that risk...
Dependence in prestroke mobility predicts adverse outcomes among patients with acute ischemic strokeMary I Dallas
Clinical Epidemiology Research Center, Physical Medicine and Rehabilitation, VA Connecticut Healthcare System, West Haven, Conn 06516, USA
Stroke 39:2298-303. 2008..The secondary objective was to evaluate the association between prestroke mobility impairment and a plan for physical therapy...
National trends in outcomes among elderly patients with heart failureMikhail Kosiborod
Mid America Heart Institute of Saint Luke's Hospital, Kansas City, MO, USA
Am J Med 119:616.e1-7. 2006..These findings suggest that recent innovations in heart failure management have not yet translated into better outcomes in this population...
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trialHans Christoph Diener
Department of Neurology, University of Essen, Hufelandstrasse 55, 45122 Essen, Germany
Lancet 364:331-7. 2004..We aimed to assess whether addition of aspirin to clopidogrel could have a greater benefit than clopidogrel alone in prevention of vascular events with potentially higher bleeding risk...
Management of atherothrombosis with clopidogrel in high-risk patients with recent transient ischaemic attack or ischaemic stroke (MATCH): study design and baseline dataHans Christoph Diener
Department of Neurology, University of Essen, Germany
Cerebrovasc Dis 17:253-61. 2004..The benefit of clopidogrel over ASA is amplified in high-risk patients. Proof of concept for the benefit of clopidogrel in addition to ASA in patients with coronary manifestations of atherothrombosis was provided by the CURE trial...
Influence of race, clinical, and other socio-demographic features on trial participationGiselle Corbie-Smith
Department of Social Medicine, Division of General Medicine and Clinical Epidemiology, University of North Carolina at Chapel Hill, Wing D, Medical School, CB 7240, Chapel Hill, NC 27599, USA
J Clin Epidemiol 56:304-9. 2003..94-0.97), hysterectomy (OR 1.78, 95% CI 1.27-2.50), no cognitive impairment (OR 1.70, 95% CI 1.10-2.63), history of volunteerism (OR 1.62, 95% CI 1.02-2.63), and previous estrogen use (RR 1.58, 95% CI 1.08-2.30)...
Estrogen and stroke: a balanced analysisPatricia D Hurn
Department of Anesthesiology and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA
Stroke 34:338-41. 2003
Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack CoalitionMark J Alberts
Northwestern University Medical School, 710 N Lake Shore Dr, Room 1420, Chicago, IL 60611, USA
Stroke 36:1597-616. 2005....
Major risk factors for intracerebral hemorrhage in the young are modifiableEdward Feldmann
Department of Clinical Neurosciences, Brown Medical School, 110 Lockwood St, Providence, RI 02903, USA
Stroke 36:1881-5. 2005..To identify risk factors for intracerebral hemorrhage (ICH), we examined data from the Hemorrhagic Stroke Project (HSP), a case-control study of hemorrhagic stroke among men and women aged 18 to 49 years...
ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing ComRobert L McNamara
J Am Coll Cardiol 44:475-95. 2004
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood InstituteSidney C Smith
J Am Coll Cardiol 47:2130-9. 2006
Improving quality of care through disease management: principles and recommendations from the American Heart Association's Expert Panel on Disease ManagementDavid P Faxon
Stroke 35:1527-30. 2004
Improving quality of care through disease management: principles and recommendations from the American Heart Association's Expert Panel on Disease ManagementDavid P Faxon
Circulation 109:2651-4. 2004
ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing ComRobert L McNamara
Circulation 109:3223-43. 2004
Research Grants
- Stroke Hospitalization in the Elderly with Medicare FFSLawrence Brass; Fiscal Year: 2005....
